Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
C16 Biosciences Inc. holds a company patent portfolio in the Chemistry & Materials technology area. The portfolio currently includes 1 pending office action. This 1 action is assigned to a distinct examiner and is located within a distinct art unit, indicating a concentrated prosecution focus for the company.
HAWKINS, AMANDA SALATA is the busiest examiner for this portfolio, responsible for the 1 pending office action. As this is the only active matter, this examiner is the sole individual reviewing the company's pending intellectual property. Practitioners should focus on the specific examination style of this individual to ensure an efficient prosecution process.
The placement of the action within a distinct art unit suggests that the pending Chemistry & Materials technology is specialized. Because the busiest examiner pending count is 1, there is no overlap or conflict with other examiners. This allows the practitioner to maintain a unified and consistent argument throughout the prosecution of the pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAWKINS, AMANDA SALATA | 1 | 15.4% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17885280 | MICROBIALLY PRODUCED PALM OIL SUBSTITUTES | HAWKINS, AMANDA SALATA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17885280 | MICROBIALLY PRODUCED PALM OIL SUBSTITUTES | HAWKINS, AMANDA SALATA | — |
| Art Unit | Apps |
|---|---|
| 1793 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17885280 | MICROBIALLY PRODUCED PALM OIL SUBSTITUTES | HAWKINS, AMANDA SALATA | 1793 | §103 | Non-Final OA | — | Pending | Aug 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialC16 Biosciences Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Amanda Salata Hawkins has the most, with 1 of C16 Biosciences Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
